{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:15:57Z","timestamp":1740122157427,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10620-022-07686-3","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T02:02:27Z","timestamp":1663120947000},"page":"685-698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7112-3479","authenticated-orcid":false,"given":"Yuichi","family":"Honma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiko","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kahori","family":"Morino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudai","family":"Koya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuguru","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyoshi","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kusanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Oe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinari","family":"Tabaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"7686_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301\u20131314.","journal-title":"Lancet."},{"key":"7686_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/cid\/cir306","volume":"53","author":"SS El-Kamary","year":"2011","unstructured":"El-Kamary SS, Jhaveri R, Shardell MD. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population. Clin Infect Dis. 2011;53:150\u2013157.","journal-title":"Clin Infect Dis."},{"key":"7686_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0168-8278(92)90073-X","volume":"15","author":"AL Zignego","year":"1992","unstructured":"Zignego AL, Macchia D, Monti M et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol. 1992;15:382\u2013386.","journal-title":"J Hepatol."},{"key":"7686_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/jhep.2000.8533","volume":"32","author":"JJ Arrieta","year":"2000","unstructured":"Arrieta JJ, Rodriguez-Inigo E, Casqueiro M et al. Detection of hepatitis C virus replication by in situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus. Hepatology. 2000;32:97\u2013103.","journal-title":"Hepatology."},{"key":"7686_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0168-8278(02)00183-6","volume":"37","author":"M Carrozzo","year":"2002","unstructured":"Carrozzo M, Quadri R, Latorre P et al. Molecular evidence that the hepatitis C virus replicates in the oral mucosa. J Hepatol. 2002;37:364\u2013369.","journal-title":"J Hepatol."},{"key":"7686_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/hep.510310127","volume":"31","author":"S De Vita","year":"2000","unstructured":"De Vita S, De Re V, Sansonno D et al. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis. Hepatology. 2000;31:182\u2013189.","journal-title":"Hepatology."},{"key":"7686_CR7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3748\/wjg.v6.i6.805","volume":"6","author":"FM Yan","year":"2000","unstructured":"Yan FM, Chen AS, Hao F et al. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol. 2000;6:805\u2013811.","journal-title":"World J Gastroenterol."},{"key":"7686_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jhep.2003.10.009","volume":"40","author":"V Agnello","year":"2004","unstructured":"Agnello V, De Rosa FG. Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol. 2004;40:341\u2013352.","journal-title":"J Hepatol."},{"key":"7686_CR9","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jhep.2015.04.021","volume":"63","author":"RD Allison","year":"2015","unstructured":"Allison RD, Tong X, Moorman AC et al. Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006\u20132010. J Hepatol. 2015;63:822\u2013828.","journal-title":"J Hepatol."},{"key":"7686_CR10","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","volume":"149","author":"F Negro","year":"2015","unstructured":"Negro F, Forton D, Crax\u00ec A, Sulkowski MS, Feld JJ, Manns MP. Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology. 2015;149:1345\u20131360.","journal-title":"Gastroenterology."},{"key":"7686_CR11","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","volume":"153","author":"F Kanwal","year":"2017","unstructured":"Kanwal F, Kramer J, Asch SM, Chayanupatkul M, Cao Y, El-Serag HB. Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents. Gastroenterology. 2017;153:996\u20131005.","journal-title":"Gastroenterology."},{"key":"7686_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12072-019-09939-2","volume":"13","author":"T Ide","year":"2019","unstructured":"Ide T, Koga H, Nakano M et al. Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study. Hepatol Int. 2019;13:293\u2013301.","journal-title":"Hepatol Int."},{"key":"7686_CR13","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jhep.2017.07.025","volume":"67","author":"R Waziry","year":"2017","unstructured":"Waziry R, Hajarizadeh B, Grebely J et al. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analysis, and meta-regression. J Hepatol. 2017;67:1204\u20131212.","journal-title":"J Hepatol."},{"key":"7686_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jhep.2017.08.030","volume":"68","author":"GN Ioannou","year":"2018","unstructured":"Ioannou GN, Green PK, Berry K. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma. J Hepatol. 2018;68:25\u201332.","journal-title":"J Hepatol."},{"key":"7686_CR15","doi-asserted-by":"publisher","first-page":"12896","DOI":"10.3748\/wjg.v21.i45.12896","volume":"21","author":"S Fiorino","year":"2015","unstructured":"Fiorino S, Bacchi-Reggiani L, de Biase D et al. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: a systematic review. World J Gastroenterol. 2015;21:12896\u201312953.","journal-title":"World J Gastroenterol."},{"key":"7686_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/hep.30034","volume":"68","author":"M Allaire","year":"2018","unstructured":"Allaire M, Nahon P, Layese R et al. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication. Hepatology. 2018;68:1245\u20131259.","journal-title":"Hepatology."},{"key":"7686_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jgh3.12097","volume":"3","author":"K Yamamoto","year":"2018","unstructured":"Yamamoto K, Kogiso T, Taniai M, Hashimoto E, Tokushige K. Differences in the genetic backgrounds of patients with alcoholic liver disease and non-alcoholic fatty liver disease. JGH Open. 2018;3:17\u201324.","journal-title":"JGH Open."},{"key":"7686_CR18","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/aje\/kwq224","volume":"172","author":"PC Austin","year":"2010","unstructured":"Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol. 2010;172:1092\u20131097.","journal-title":"Am J Epidemiol."},{"key":"7686_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/liv.13071","volume":"36","author":"T Tada","year":"2016","unstructured":"Tada T, Kumada T, Toyoda H et al. Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis. Liver Int. 2016;36:817\u2013826.","journal-title":"Liver Int."},{"key":"7686_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/j.1600-0714.1995.tb01199.x","volume":"24","author":"Y Nagao","year":"1995","unstructured":"Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T. High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med. 1995;24:354\u2013360.","journal-title":"J Oral Pathol Med."},{"key":"7686_CR21","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1053\/j.gastro.2003.09.025","volume":"125","author":"JP Gisbert","year":"2003","unstructured":"Gisbert JP, Garc\u00eda-Buey L, Pajares JM, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin\u2019s lymphoma: systematic review and meta-analysis. Gastroenterology. 2003;125:1723\u20131732.","journal-title":"Gastroenterology."},{"key":"7686_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.22606","volume":"49","author":"HB El-Serag","year":"2009","unstructured":"El-Serag HB, Engels EA, Landgren O et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U.S. veterans. Hepatology. 2009;49:116\u2013123.","journal-title":"Hepatology."},{"key":"7686_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/1471-2407-11-495","volume":"11","author":"FH Su","year":"2011","unstructured":"Su FH, Chang SN, Chen PC, Sung FC, Su CT, Yeh CC. Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study. BMC Cancer.\u00a02011;11:495.","journal-title":"BMC Cancer"},{"key":"7686_CR24","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/cam4.988","volume":"6","author":"X Liu","year":"2017","unstructured":"Liu X, Chen Y, Wang Y et al. Cancer risk in patients with hepatitis C virus infection: a population-based study in Sweden. Cancer Med. 2017;6:1135\u20131140.","journal-title":"Cancer Med."},{"key":"7686_CR25","doi-asserted-by":"publisher","first-page":"8349150","DOI":"10.1155\/2017\/8349150","volume":"2017","author":"S Qadwai","year":"2017","unstructured":"Qadwai S, Rehman T, Barsa J, Solangi Z, Lebovics E. Hepatitis C virus and nonliver solid cancers: is there an association between HCV and cancers of the pancreas, thyroid, kidney, oral cavity, breast, lung, and gastrointestinal tract? Gastroenterol Res Pract. 2017;2017:8349150.","journal-title":"Gastroenterol Res Pract."},{"key":"7686_CR26","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1002\/cncr.30559","volume":"123","author":"P Mahale","year":"2017","unstructured":"Mahale P, Torres HA, Kramer JR et al. Hepatitis C virus infection and the risk of cancer among elderly US adults: a registry-based case\u2013control study. Cancer. 2017;123:1202\u20131211.","journal-title":"Cancer."},{"key":"7686_CR27","doi-asserted-by":"publisher","first-page":"19444","DOI":"10.1038\/s41598-019-55249-w","volume":"9","author":"B Liu","year":"2019","unstructured":"Liu B, Zhang Y, Li J, Zhang W. Hepatitis C virus and risk of extrahepatic malignancies: a case\u2013control study. Sci Rep. 2019;9:19444.","journal-title":"Sci Rep."},{"key":"7686_CR28","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1128\/jvi.70.7.4438-4443.1996","volume":"70","author":"RB Ray","year":"1996","unstructured":"Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with rats and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol. 1996;70:4438\u20134443.","journal-title":"J Virol."},{"key":"7686_CR29","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/2053","volume":"4","author":"K Moriya","year":"1998","unstructured":"Moriya K, Fujie H, Shintani Y et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med. 1998;4:1065\u20131067.","journal-title":"Nat Med."},{"key":"7686_CR30","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.3390\/v2092108","volume":"2","author":"A Banerjee","year":"2010","unstructured":"Banerjee A, Ray RB, Ray R. Oncogenic potential of hepatitis C virus proteins. Viruses. 2010;2:2108\u20132133.","journal-title":"Viruses."},{"key":"7686_CR31","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrgastro.2017.172","volume":"15","author":"S Pol","year":"2018","unstructured":"Pol S, Vallet-Pichard A, Hermine O. Extrahepatic cancers and chronic HCV infection. Nat Rev Gastroenterol Hepatol. 2018;15:283\u2013290.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"7686_CR32","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/hep.27766","volume":"62","author":"HA Innes","year":"2015","unstructured":"Innes HA, McDonald SA, Dillon JF et al. Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes. Hepatology. 2015;62:355\u2013364.","journal-title":"Hepatology."},{"key":"7686_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/MCG.0000000000000892","volume":"51","author":"PJ Gaglio","year":"2017","unstructured":"Gaglio PJ. Extrahepatic and intrahepatic malignancies in patients with HCV who achieve an SVR with directly acting antiviral agents: should we be concerned that DAA therapy contributed to this phenomenon? J Clin Gastroenterol. 2017;51:657\u2013658.","journal-title":"J Clin Gastroenterol."},{"key":"7686_CR34","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMra0804615","volume":"361","author":"JH Hoeijmakers","year":"2009","unstructured":"Hoeijmakers JH. DNA damage, aging, and cancer. N Engl J Med. 2009;361:1475\u20131485.","journal-title":"N Engl J Med."},{"key":"7686_CR35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fgene.2012.00268","volume":"3","author":"MT Dorak","year":"2012","unstructured":"Dorak MT, Karpuzoglu E. Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet. 2012;3:268.","journal-title":"Front Genet."},{"key":"7686_CR36","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1126\/science.aag0299","volume":"354","author":"LB Alexandrov","year":"2016","unstructured":"Alexandrov LB, Ju YS, Haase K et al. Mutational signatures associated with tobacco smoking in human cancer. Science. 2016;354:618\u2013622.","journal-title":"Science."},{"key":"7686_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1470-2045(06)70577-0","volume":"7","author":"P Boffetta","year":"2006","unstructured":"Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol. 2006;7:149\u2013156.","journal-title":"Lancet Oncol."},{"key":"7686_CR38","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00125-010-1796-7","volume":"53","author":"XH Zhou","year":"2010","unstructured":"Zhou XH, Qiao Q, Zethelius B et al. Diabetes, prediabetes and cancer mortality. Diabetologia. 2010;53:1867\u20131876.","journal-title":"Diabetologia."},{"key":"7686_CR39","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1008862","volume":"364","author":"S Rao Kondapally Seshasai","year":"2011","unstructured":"Rao Kondapally Seshasai S, Kaptoge S, Thompson A et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364:829\u2013841.","journal-title":"N Engl J Med."},{"key":"7686_CR40","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1053\/j.gastro.2007.03.050","volume":"132","author":"E Giovannucci","year":"2007","unstructured":"Giovannucci E, Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology. 2007;132:2208\u20132225.","journal-title":"Gastroenterology."},{"key":"7686_CR41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569\u2013578.","journal-title":"Lancet."},{"key":"7686_CR42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nri3845","volume":"15","author":"L Zitvogel","year":"2015","unstructured":"Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nat Rev Immunol. 2015;15:405\u2013414.","journal-title":"Nat Rev Immunol."},{"key":"7686_CR43","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","volume":"65","author":"M Reig","year":"2016","unstructured":"Reig M, Mari\u00f1o Z, Perell\u00f3 C et al. Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy. J Hepatol. 2016;65:719\u2013726.","journal-title":"J Hepatol."},{"key":"7686_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12328-017-0789-1","volume":"11","author":"T Kawaguchi","year":"2018","unstructured":"Kawaguchi T, Ide T, Koga H et al. Rapidly growing hepatocellular carcinoma after direct-acting antiviral treatment of chronic hepatitis C. Clin J Gastroenterol. 2018;11:69\u201374.","journal-title":"Clin J Gastroenterol."},{"key":"7686_CR45","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.jhep.2017.11.011","volume":"68","author":"Y Nakao","year":"2018","unstructured":"Nakao Y, Hashimoto S, Abiru S et al. Rapidly growing, moderately differentiated HCC: a clinicopathological characteristic of HCC occurrence after IFN-free DAA therapy? J Hepatol. 2018;68:854\u2013855.","journal-title":"J Hepatol."},{"key":"7686_CR46","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin."},{"key":"7686_CR47","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/hepr.12393","volume":"45","author":"N Hiramatsu","year":"2015","unstructured":"Hiramatsu N, Oze T, Takehara T. Suppression of hepatocellular carcinoma development in hepatitis C patients given interferon-based antiviral therapy. Hepatol Res. 2015;45:152\u2013161.","journal-title":"Hepatol Res."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07686-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07686-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07686-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T21:06:20Z","timestamp":1676063180000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07686-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["7686"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07686-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"assertion":[{"value":"4 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflict of interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol conformed to the ethical guidelines of the Declaration of Helsinki and was approved by the Ethics Committee of the University of Occupational and Environmental Health (Confirmation No.: UOEHCRB20-189).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}